Evaxion A/S (EVAX) — SEC Filings

Latest SEC filings for Evaxion A/S (EVAX), explained in plain English.

Sentiment Overview: 50 neutral

Recent Filings (50)

• 6-K Filing — 6-K · 2026-03-30T08:05:06-04:00 [neutral]
• 6-K Filing — 6-K · 2025-12-19T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-12-10T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-12-08T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-11-20T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-11-18T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-11-12T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-11-07T00:00:00.000Z [neutral]
• 6-K Filing — 6-K · 2025-11-06T00:00:00.000Z [neutral]
• Evaxion A/S Files November 2025 Form 6-K — 6-K · 2025-11-03T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on November 3, 2025. This report is for the month of November 2025 and indicates the company is a foreign
• 6-K Filing — 6-K · 2025-10-31T00:00:00.000Z [neutral]
• Evaxion A/S Files October 2025 Form 6-K — 6-K · 2025-10-30T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on October 30, 2025, to report its activities for the month of October 2025. The company is incorporated
• Evaxion A/S Files Form 6-K — 6-K · 2025-10-27T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on October 27, 2025. The filing is a report of a foreign private issuer and indicates that the company fi
• Evaxion A/S Files 6-K Report — 6-K · 2025-10-17T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on October 17, 2025. The filing is a report of a foreign private issuer and indicates that the company fi
• Evaxion A/S Files October 2025 6-K Report — 6-K · 2025-10-14T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S filed a Form 6-K on October 14, 2025, for the month of October 2025. The company, previously known as Evaxion Biotech A/S until October 14, 2020, is
• Evaxion A/S Files October 2025 6-K Report — 6-K · 2025-10-08T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on October 8, 2025, reporting for the month of October 2025. The company is incorporated in G7 and has it
• Evaxion A/S Files October 2025 6-K Report — 6-K · 2025-10-06T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on October 6, 2025, for the month of October 2025. The filing is a report of a foreign private issuer and
• Evaxion A/S Files Form 6-K for September 2025 — 6-K · 2025-09-25T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on September 25, 2025. This report is for the month of September 2025 and indicates the company is submit
• Evaxion A/S Files Form 6-K — 6-K · 2025-08-27T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on August 27, 2025. This filing is a report of a foreign private issuer and indicates that the company fi
• Evaxion A/S Files 6-K Report — 6-K · 2025-08-14T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S, now Evaxion A/S, filed a Form 6-K on August 14, 2025, reporting for the period ending June 30, 2025. The filing includes exhibits 99.1 and
• Evaxion A/S Files August 2025 Report on Form 6-K — 6-K · 2025-08-11T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on August 11, 2025, to report its activities for the month of August 2025. The filing indicates the compa
• Evaxion A/S Files July 2025 6-K Report — 6-K · 2025-07-25T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on July 25, 2025. This report is for the month of July 2025 and indicates that the company is a foreign p
• Evaxion A/S Files July 2025 6-K Report — 6-K · 2025-07-17T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S filed a Form 6-K on July 17, 2025, to report information for the month of July 2025. This filing incorporates by reference previous registration sta
• Evaxion A/S Files Form 6-K with SEC — 6-K · 2025-07-11T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on July 11, 2025. The filing is a report of a foreign private issuer and indicates that the company files
• Evaxion A/S Files Routine 6-K Report — 6-K · 2025-07-02T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S filed a Form 6-K on July 2, 2025, for the month of July 2025. The company, previously known as Evaxion Biotech A/S, is a foreign private issuer base
• Evaxion A/S Files June 2025 Report on Form 6-K — 6-K · 2025-06-25T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on June 25, 2025, to report its activities for the month of June 2025. The filing indicates the company i
• Evaxion A/S Files Form 6-K — 6-K · 2025-06-03T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on June 3, 2025. The filing is a report of a foreign private issuer and indicates that the company files
• Evaxion A/S Files Form 6-K — 6-K · 2025-05-27T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on May 27, 2025. The filing is a report of a foreign private issuer and indicates that the company files
• Evaxion A/S Files May 2025 Report on Form 6-K — 6-K · 2025-05-23T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S filed a Form 6-K on May 23, 2025, reporting its activities for the month of May 2025. The company, previously known as Evaxion Biotech A/S, is incor
• Evaxion A/S Files Form 6-K — 6-K · 2025-05-22T00:00:00.000Z [neutral] Risk: low
  Evaxion A/S, a biotechnology company, filed a Form 6-K on May 22, 2025. The filing is a report of a foreign private issuer and indicates that the company files
• Evaxion Biotech Files 6-K, Incorporates by Reference — 6-K · 2025-05-05T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on May 5, 2025, to report its activities for the month of May 2025. The company is incorporated in Denmark and its principa
• Evaxion Biotech Files April 2025 6-K Report — 6-K · 2025-04-29T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on April 29, 2025, to report for the month of April 2025. The filing incorporates by reference previous registration statem
• Evaxion Biotech Files 6-K, Confirms 20-F Reporting — 6-K · 2025-04-28T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S, a biotechnology company, filed a Form 6-K on April 28, 2025. This report is for foreign private issuers and indicates that Evaxion Biotech
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-04-10T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on April 10, 2025, to report its activities for the month of April 2025. The company, incorporated in G7 with its principal
• Evaxion Biotech Files 6-K, Incorporates by Reference — 6-K · 2025-04-07T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on April 7, 2025, for the month of April. This report is for a foreign private issuer and is incorporated by reference into
• Evaxion Biotech A/S Files 2024 Annual Report — 20-F · 2025-04-01T00:00:00.000Z [neutral] Risk: medium
  Evaxion Biotech A/S filed its 20-F for the fiscal year ending December 31, 2024. The report details financial performance and business operations, including inf
• Evaxion Biotech A/S Files March 2025 6-K Report — 6-K · 2025-03-27T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on March 27, 2025, to report for the month of March 2025. The company is a foreign private issuer based in Hoersholm, Denma
• Evaxion Biotech Incorporates Filings into Registration Statements — 6-K · 2025-03-26T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on March 26, 2025, to incorporate by reference its previous filings into various registration statements. These include S-8
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-03-25T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on March 25, 2025, reporting for the month of March 2025. The company, incorporated in G7 with its principal executive offi
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-03-04T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on March 4, 2025, to report for the month of March 2025. The company is a foreign private issuer and files annual reports u
• Evaxion Biotech Files 6-K Report — 6-K · 2025-02-25T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S, a biotechnology company, filed a Form 6-K on February 25, 2025. The filing is a report of a foreign private issuer and indicates that the c
• Evaxion Biotech Files Form 6-K for February 2025 — 6-K · 2025-02-14T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S, a biotechnology company, filed a Form 6-K on February 14, 2025. This report is for the month of February 2025 and indicates that the compan
• Evaxion Biotech Files 6-K, Incorporates by Reference — 6-K · 2025-02-12T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on February 12, 2025, for the month of February 2025. This report is incorporated by reference into several of their existi
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-01-31T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 31, 2025, for the month of January 2025. The company, incorporated in G7 with its principal executive office in
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-01-30T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 30, 2025, to report its activities for the month of January 2025. The company, incorporated in G7 and headquarte
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-01-28T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 28, 2025, reporting for the month of January 2025. The company, incorporated in G7 with its principal executive
• Evaxion Biotech A/S Files 6-K, Incorporates into Filings — 6-K · 2025-01-27T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 27, 2025, for the month of January 2025. The report is incorporated by reference into several of Evaxion's exist
• Evaxion Biotech Files 6-K, Incorporates by Reference — 6-K · 2025-01-21T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 21, 2025, for the month of January 2025. This report is for a foreign private issuer and is incorporated by refe
• Evaxion Biotech Files 6-K Report — 6-K · 2025-01-15T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 15, 2025, to report information for the month of January 2025. The company is a foreign private issuer based in
• Evaxion Biotech Files Routine 6-K Report — 6-K · 2025-01-14T00:00:00.000Z [neutral] Risk: low
  Evaxion Biotech A/S filed a Form 6-K on January 14, 2025, to report information for the month of January 2025. The company, incorporated in G7 with its principa